Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 7
1946 5
1947 7
1948 9
1949 2
1950 6
1951 12
1952 15
1953 10
1954 11
1955 16
1956 10
1957 17
1958 10
1959 16
1960 14
1961 14
1962 14
1963 27
1964 31
1965 11
1966 1
1967 6
1968 22
1969 26
1970 20
1971 41
1972 29
1973 24
1974 26
1975 22
1976 29
1977 24
1978 26
1979 44
1980 25
1981 26
1982 34
1983 30
1984 50
1985 40
1986 43
1987 57
1988 52
1989 49
1990 57
1991 45
1992 42
1993 50
1994 57
1995 54
1996 69
1997 72
1998 69
1999 69
2000 55
2001 67
2002 59
2003 77
2004 77
2005 79
2006 95
2007 100
2008 113
2009 111
2010 98
2011 120
2012 118
2013 103
2014 110
2015 157
2016 132
2017 149
2018 123
2019 115
2020 122
2021 147
2022 121
2023 112
2024 101
2025 49

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,995 results

Results by year

Filters applied: . Clear all
Page 1
Malignant Sweat Gland Tumors.
Ahn CS, Sangüeza OP. Ahn CS, et al. Hematol Oncol Clin North Am. 2019 Feb;33(1):53-71. doi: 10.1016/j.hoc.2018.09.002. Hematol Oncol Clin North Am. 2019. PMID: 30497677 Review.
Porocarcinoma: a review.
Joshy J, Mistry K, Levell NJ, van Bodegraven B, Vernon S, Rajan N, Craig P, Venables ZC. Joshy J, et al. Clin Exp Dermatol. 2022 Jun;47(6):1030-1035. doi: 10.1111/ced.15126. Epub 2022 Mar 20. Clin Exp Dermatol. 2022. PMID: 35149987 Review.
Sweat gland carcinoma.
Chambers JA, Lipschitz AH, Petrisor D, Garcia-Mitchell CA, Stepenaskie-Wolz S. Chambers JA, et al. Plast Reconstr Surg. 2009 Jan;123(1):33e-35e. doi: 10.1097/PRS.0b013e31819056cc. Plast Reconstr Surg. 2009. PMID: 19116525 No abstract available.
Ancillary immunohistochemical and molecular testing in the classification of cutaneous sweat gland/duct neoplasms: A validation study with emphasis on histomorphologic correlation and pathological diagnosis.
Nguyen AJ, Johnson E, Camilleri M, Wieland C, Lehman JS, Agrawal S, Comfere N, Fadra N, Knudson RA, Greipp P, Halling K, Ray Guo R. Nguyen AJ, et al. Hum Pathol. 2024 Aug;150:1-8. doi: 10.1016/j.humpath.2024.06.006. Epub 2024 Jun 12. Hum Pathol. 2024. PMID: 38876201
Sweat gland carcinoma.
Brichkov I, Daskalakis T, Rankin L, Divino C. Brichkov I, et al. Am Surg. 2004 Jan;70(1):63-6. Am Surg. 2004. PMID: 14964551 Review.
Malignant sweat gland tumours: an update.
Cardoso JC, Calonje E. Cardoso JC, et al. Histopathology. 2015 Nov;67(5):589-606. doi: 10.1111/his.12767. Epub 2015 Jul 21. Histopathology. 2015. PMID: 26114606 Review.
Reactive syringofibroadenoma.
Kumar P, Das A, Das PC. Kumar P, et al. Indian J Dermatol Venereol Leprol. 2020 Nov-Dec;86(6):681-682. doi: 10.4103/ijdvl.IJDVL_924_18. Indian J Dermatol Venereol Leprol. 2020. PMID: 31249214 Free article. No abstract available.
[Syringocystadenoma papilliferum].
Baino A, Akhdari N, Amal S, Hamdaoui A, Abbad F, Rais H. Baino A, et al. Ann Dermatol Venereol. 2015 Jun-Jul;142(6-7):460-2. doi: 10.1016/j.annder.2015.03.024. Epub 2015 May 5. Ann Dermatol Venereol. 2015. PMID: 25956460 Review. French. No abstract available.
Generalized Eruptive Syringoma.
Wang Q, Liu J. Wang Q, et al. J Cutan Med Surg. 2024 May-Jun;28(3):313. doi: 10.1177/12034754241229645. Epub 2024 Feb 15. J Cutan Med Surg. 2024. PMID: 38357853 No abstract available.
3,995 results